Back to Search
Start Over
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
- Source :
- Morrison, A P, Pyle, M, Gumley, A, Schwannauer, M, Turkington, D, Maclennan, G, Norrie, J, Hudson, J, Bowe, S E, French, P, Byrne, R, Syrett, S, Dudley, R, Mcleod, H J, Griffiths, H, Barnes, T R E, Davies, L, Kingdon, D, Aydinlar, S, Courtley, J, Douglas-bailey, M, Graves, E, Holden, N, Hutton, J, Hutton, P, Irving, S, Jackson, C, Lebert, T, Mander, H, Mccartney, L, Munro-clark, T, Murphy, E K, Spanswick, M, Steele, A, Tip, L & Tully, S 2018, ' Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial ', The Lancet Psychiatry, vol. 5, no. 8, pp. 633-643 . https://doi.org/10.1016/S2215-0366(18)30184-6
- Publication Year :
- 2018
-
Abstract
- BackgroundAlthough clozapine is the treatment of choice for treatment-refractory schizophrenia, 30–40% of patients have an insufficient response, and others are unable to tolerate it. Evidence for any augmentation strategies is scarce. We aimed to determine whether cognitive behavioural therapy (CBT) is an effective treatment for clozapine-resistant schizophrenia.MethodsWe did a pragmatic, parallel group, assessor-blinded, randomised controlled trial in community-based and inpatient mental health services in five sites in the UK. Patients with schizophrenia who were unable to tolerate clozapine, or whose symptoms did not respond to the drug, were randomly assigned 1:1 by use of randomised-permuted blocks of size four or six, stratified by centre, to either CBT plus treatment as usual or treatment as usual alone. Research assistants were masked to allocation to protect against rater bias and allegiance bias. The primary outcome was the Positive and Negative Syndrome Scale (PANSS) total score at 21 months, which provides a continuous measure of symptoms of schizophrenia; PANSS total was also assessed at the end of treatment (9 months). The primary analysis was by randomised treatment based on intention to treat, for all patients for whom data were available. This study was prospectively registered, number ISRCTN99672552. The trial is closed to accrual.FindingsFrom Jan 1, 2013, to May 31, 2015, we randomly assigned 487 participants to either CBT and treatment as usual (n=242) or treatment as usual alone (n=245). Analysis included 209 in the CBT group and 216 in the treatment as usual group. No difference occurred in the primary outcome (PANSS total at 21 months, mean difference −0·89, 95% CI −3·32 to 1·55; p=0·48), although the CBT group improved at the end of treatment (PANSS total at 9 months, mean difference −2·40, −4·79 to −0·02; p=0·049). During the trial, 107 (44%) of 242 participants in the CBT arm and 104 (42%) of 245 in the treatment as usual arm had at least one adverse event (odds ratio 1·09, 95% CI 0·81 to 1·46; p=0·58). Only two (1%) of 242 participants in the CBT arm and one (
- Subjects :
- 616.8 Nervous & mental disorders
Psychiatry and Mental health
Health
mental disorders
Mental health
Schizophrenia, clozapine, drug treatment, cognitive behavioural therapy, CBT
Centre for Mental Health Practice, Policy and Law Research
RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
behavioral disciplines and activities
Biological Psychiatry
Subjects
Details
- Language :
- English
- ISSN :
- 22150366
- Database :
- OpenAIRE
- Journal :
- Morrison, A P, Pyle, M, Gumley, A, Schwannauer, M, Turkington, D, Maclennan, G, Norrie, J, Hudson, J, Bowe, S E, French, P, Byrne, R, Syrett, S, Dudley, R, Mcleod, H J, Griffiths, H, Barnes, T R E, Davies, L, Kingdon, D, Aydinlar, S, Courtley, J, Douglas-bailey, M, Graves, E, Holden, N, Hutton, J, Hutton, P, Irving, S, Jackson, C, Lebert, T, Mander, H, Mccartney, L, Munro-clark, T, Murphy, E K, Spanswick, M, Steele, A, Tip, L & Tully, S 2018, ' Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial ', The Lancet Psychiatry, vol. 5, no. 8, pp. 633-643 . https://doi.org/10.1016/S2215-0366(18)30184-6
- Accession number :
- edsair.dedup.wf.001..a69300d42a3bfc48692ecaca7e27a10e